Early clinical outcomes as a function of use of newer oral P2Y(12) inhibitors versus clopidogrel in the EUROMAX trial

OBJECTIVE: To ascertain whether different oral P2Y(12) inhibitors might affect rates of acute stent thrombosis and 30-day outcomes after primary percutaneous coronary intervention (pPCI). METHODS: The European Ambulance Acute Coronary Syndrome Angiography (EUROMAX) randomised trial compared prehospi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Kurt, Ducrocq, Gregory, Hamm, Christian W, van ’t Hof, Arnoud, Lapostolle, Frédéric, Coste, Pierre, Gordini, Giovanni, Steinmetz, Jacob, Verheugt, Freek W A, Adgey, Jennifer, Nibbe, Lutz, Kaniĉ, Vojko, Clemmensen, Peter, Zeymer, Uwe, Bernstein, Debra, Prats, Jayne, Deliargyris, Efthymios N, Gabriel Steg, Ph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Interventional Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708315/
https://www.ncbi.nlm.nih.gov/pubmed/29225903
http://dx.doi.org/10.1136/openhrt-2017-000677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708315/
https://www.ncbi.nlm.nih.gov/pubmed/29225903
http://dx.doi.org/10.1136/openhrt-2017-000677

Ejemplares similares